openPR Logo
Press release

Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver

08-28-2018 04:22 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs

Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital Associated MRSA Infection (HA-MRSA) or community-associated MRSA infections (CA-MRSA). Staphylococcus aureus leads to skin infections such as boils, pimples, impetigo, abscesses or certain life threatening conditions such as septicemia (blood poisoning), pneumonia (lung infection), osteomyelitis (bone infection), endocarditis (heart valve infection), urinary tract infection, and septic bursitis (formation of small fluid-filled sacs under the skin). Growth of the methicillin-resistant staphylococcus aureus (MRSA) drug market is driven by increasing product pipeline and increasing adoption of organic and inorganic strategies by key market players.

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1538

Increasing number of pipeline products for the treatment of methicillin resistance staphylococcus aureus infection is expected to fuel growth of the Methicillin-Resistant Staphylococcus Aureus (MRSA) drug market during the forecast period. For instance, in 2014, Cubist Pharmaceuticals Inc., received US FDA approval for its new antibiotic, Sivextro, available in both the forms – injection as well as oral, to treat skin infection caused by gram positive bacteria including MRSA. Moreover, new route of administration are experimented by market players to treat MRSA infection. For instance, in 2018, Destiny Pharma received investigational new drug application from FDA for its new candidate, XF-73, a dicationic porphyrin molecule based nasal gel, to combat with post-surgical infections of methicillin-resistant Staphylococcus aureus (MRSA). These increasing number of product approvals is expected to aid in growth of the MRSA drugs market over the forecast period.

Moreover, funding programs by healthcare organization will also propel drug discovery and development program, in turn leading to growth of the MRSA drug market. For instance, in 2017, Cystic Fibrosis Foundation Therapeutics (CFFT)—a non-profit drug discovery and development arm of Cystic Fibrosis Foundation—awarded US$ 5 million to Savara Inc., a clinical-stage specialty pharmaceutical company, for the development of AeroVanc, vancomycin hydrochloride inhalation powder, intended to treat MRSA lung infection in individual with cystic fibrosis.

Download The PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1538

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver here

News-ID: 1207098 • Views: 551

More Releases from Coherent Market Insights

Latin America Oncology Device Market In-Depth Analysis 2020 | Medtronic plc, ACE …
Latest released the research study on Global Latin America Oncology Device Market, offers a detailed overview of the factors influencing the global business scope. Latin America Oncology Device Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Latin America Oncology Device. The study
Huge Growth on Medical Nitrous Oxide Delivery Systems Market with COVID-19 Impac …
Latest released the research study on Global Medical Nitrous Oxide Delivery Systems Market, offers a detailed overview of the factors influencing the global business scope. Medical Nitrous Oxide Delivery Systems Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Medical Nitrous Oxide Delivery
Portable Slit Lamp Market In-Depth Analysis 2020 | Shin Nippon (Rexxam Co.Ltd), …
Latest released the research study on Global Portable Slit Lamp Market, offers a detailed overview of the factors influencing the global business scope. Portable Slit Lamp Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Portable Slit Lamp. The study covers emerging player’s
Rapid Growth in IV Infusion Bottle Seals & Caps Market with COVID-19 Impact Anal …
Latest released the research study on Global IV Infusion Bottle Seals & Caps Market, offers a detailed overview of the factors influencing the global business scope. IV Infusion Bottle Seals & Caps Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the IV Infusion

All 5 Releases


More Releases for MRSA

MRSA Antibiotics Global Industry Report - History, Present and Future 2025
The global market size of MRSA Antibiotics is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented
Global MRSA Testing Devices Market Highlights and Challenges 2017
Qyresearchreports include new market research report "Global MRSA Testing Devices Market Professional Survey Report 2017" to its huge collection of research reports. The global MRSA Testing Devices market has been elaborately studied, researched and detailed on in this publication by taking the assistance of advanced secondary and primary research that has been performed by the best of analysts and by making use of the best of the available techniques. The said
Global MRSA Antibiotics Market: Scenario 2025
“Global MRSA Antibiotics Industry Report" is an expert and in-depth analysis of key business and future development prospects, key determinants and restrictions, profiles of major market players, segmentation and forecasting. The study offers a comprehensive qualitative analysis of the industry's growth parameters, the current state of the market in terms of analysis of key economic situations and macroeconomic analysis. The analysis highlights the growth opportunities of key market segments along
MRSA Testing Devices Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global MRSA Testing Devices Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
MRSA Drugs Market 2022: Industry Trend, Growth & Global Forecast
MRSA Drugs Market Analysis, by Drug Origin (semisynthetic and synthetic drugs), by Drug Class, By Key Companies (Allergan, Plc, Merck Inc, Pfizer, Savara Pharmaceuticals, Sealife Pharma) - Forecast to 2022 Market Synopsis of MRSA Drugs Market: Market Scenario: Global MRSA Drugs Market is expected to reach USD 3.1 Billion by the end of the forecasted period from 2016 to 2022; it is confidently expected that this market has a bright future. Most MRSA infections
MRSA Drugs Market: Product Launches to Underscore Lucrative Growth Opportunities
Growing need to treat the methicillin-resistant staphylococcus aureus (MRSA) infections has led to an upsurge in demand for MRSA drugs. In addition, overconsumption of the antibiotics is further expected to contribute towards growth of the global MRSA drugs market. Market Research Hub (MRH) research reports provides insights on the “Methicillin-resistant Staphylococcus aureus (MRSA) - Epidemiology Forecast to 2025”. The analysis report provides an in-depth insight that offers the important opinions and